LD-2 disclosure · 1st Quarter - Report
KEMPHARM, INC.
Income$30Kfee reported
Client
- Name
- KEMPHARM, INC.
- Description
- Pharmaceutical company engaged in the discovery and development of proprietary prodrugs
- Location
- Iowa · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Prodrug therapies and improving abuse deterrence and consumer safety Anti-opioid abuse legislation
LobbyistsPHILIP ENGLISH · mr NORMAN FREDERICK LENT iii · SONJA NESBIT
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Natl Economic Council (NEC)